116 related articles for article (PubMed ID: 30096487)
1. The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats.
Noworyta-Sokołowska K; Górska AM; Gołembiowska K
Pharmacol Rep; 2018 Oct; 70(5):890-895. PubMed ID: 30096487
[TBL] [Abstract][Full Text] [Related]
2. Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.
Williams MT; Herring NR; Schaefer TL; Skelton MR; Campbell NG; Lipton JW; McCrea AE; Vorhees CV
Neuropsychopharmacology; 2007 Jun; 32(6):1404-20. PubMed ID: 17047665
[TBL] [Abstract][Full Text] [Related]
3. An examination of the effects of 5-Methoxy-n, n-di(ISO)propyltryptamine hydrochloride (Foxy) on cognitive development in rats.
Compton DM; Selinger MC; Testa EK; Larkins KD
Psychol Rep; 2006 Jun; 98(3):651-61. PubMed ID: 16933659
[TBL] [Abstract][Full Text] [Related]
4. 5-methoxy-N,N-di(iso)propyltryptamine hydrochloride (Foxy)-induced cognitive deficits in rat after exposure in adolescence.
Compton DM; Dietrich KL; Selinger MC; Testa EK
Physiol Behav; 2011 May; 103(2):203-9. PubMed ID: 21295050
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic Effects of 5-MeO-DIPT: A Psychoactive Tryptamine Derivative in Rats.
Noworyta-Sokołowska K; Kamińska K; Kreiner G; Rogóż Z; Gołembiowska K
Neurotox Res; 2016 Nov; 30(4):606-619. PubMed ID: 27461536
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats.
Skelton MR; Schaefer TL; Herring NR; Grace CE; Vorhees CV; Williams MT
Psychopharmacology (Berl); 2009 Jun; 204(2):287-97. PubMed ID: 19198809
[TBL] [Abstract][Full Text] [Related]
7. Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats.
Fantegrossi WE; Harrington AW; Kiessel CL; Eckler JR; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
Pharmacol Biochem Behav; 2006 Jan; 83(1):122-9. PubMed ID: 16460788
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites.
Kamata T; Katagi M; Kamata HT; Miki A; Shima N; Zaitsu K; Nishikawa M; Tanaka E; Honda K; Tsuchihashi H
Drug Metab Dispos; 2006 Feb; 34(2):281-7. PubMed ID: 16280455
[TBL] [Abstract][Full Text] [Related]
9. A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy.
Tanaka E; Kamata T; Katagi M; Tsuchihashi H; Honda K
Forensic Sci Int; 2006 Nov; 163(1-2):152-4. PubMed ID: 16406422
[TBL] [Abstract][Full Text] [Related]
10. A foxy intoxication.
Wilson JM; McGeorge F; Smolinske S; Meatherall R
Forensic Sci Int; 2005 Feb; 148(1):31-6. PubMed ID: 15607587
[TBL] [Abstract][Full Text] [Related]
11. Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats.
Noworyta-Sokołowska K; Kamińska K; Rzemieniec J; Wnuk A; Wojcieszak J; Górska AM; Kreiner G; Kajta M; Gołembiowska K
Forensic Toxicol; 2019; 37(1):45-58. PubMed ID: 30636982
[TBL] [Abstract][Full Text] [Related]
12. Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.
Narimatsu S; Yonemoto R; Saito K; Takaya K; Kumamoto T; Ishikawa T; Asanuma M; Funada M; Kiryu K; Naito S; Yoshida Y; Yamamoto S; Hanioka N
Biochem Pharmacol; 2006 Apr; 71(9):1377-85. PubMed ID: 16510126
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MS
Caspar AT; Gaab JB; Michely JA; Brandt SD; Meyer MR; Maurer HH
Drug Test Anal; 2018 Jan; 10(1):184-195. PubMed ID: 28342193
[TBL] [Abstract][Full Text] [Related]
14. 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter.
Sogawa C; Sogawa N; Tagawa J; Fujino A; Ohyama K; Asanuma M; Funada M; Kitayama S
Toxicol Lett; 2007 Apr; 170(1):75-82. PubMed ID: 17382495
[TBL] [Abstract][Full Text] [Related]
15. Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry.
Yan X; Xiang P; Zhao Y; Yu Z; Yan H
J Anal Toxicol; 2020 Apr; 44(5):461-469. PubMed ID: 32020169
[TBL] [Abstract][Full Text] [Related]
16. Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use.
Wang R; Xiang P; Yu Z; Shi Y
Forensic Sci Int; 2019 Nov; 304():109972. PubMed ID: 31604205
[TBL] [Abstract][Full Text] [Related]
17. N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity.
Shulgin AT; Carter MF
Commun Psychopharmacol; 1980; 4(5):363-9. PubMed ID: 6949674
[No Abstract] [Full Text] [Related]
18. Development of an LC-MS/MS method for determining 5-MeO-DIPT in dried urine spots and application to forensic cases.
Yan X; Yuan S; Yu Z; Zhao Y; Zhang S; Wu H; Yan H; Xiang P
J Forensic Leg Med; 2020 May; 72():101963. PubMed ID: 32452453
[TBL] [Abstract][Full Text] [Related]
19. A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry.
Jin MJ; Jin C; Kim JY; In MK; Kwon OS; Yoo HH
J Forensic Sci; 2011 Jul; 56(4):1044-8. PubMed ID: 21418218
[TBL] [Abstract][Full Text] [Related]
20. Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence.
Bassi M; Bilel S; Tirri M; Corli G; Di Rosa F; Gregori A; Alkilany AM; Rachid O; Roda E; Zauli G; Locatelli CA; Marti M
Psychopharmacology (Berl); 2024 Mar; 241(3):489-511. PubMed ID: 38214743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]